FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783252549> ?p ?o ?g. }

• W2783252549 endingPage "71" @default.
• W2783252549 startingPage "56" @default.
• W2783252549 abstract "Directly recorded patient experience of symptoms and health-related quality of life (HRQoL) can complement lung function and exacerbation rate data in chronic obstructive pulmonary disease (COPD) clinical studies. The FULFIL study recorded daily symptoms and activity limitation together with additional patient-reported outcomes of dyspnea and HRQoL, as part of the prespecified analyses. FULFIL co-primary endpoint data have been previously reported. FULFIL was a phase III, 24-week, randomized, double-blind, double-dummy, multicenter study comparing once-daily single inhaler triple therapy [fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI)] 100 µg/62.5 µg/25 µg with twice-daily inhaled corticosteroid/long-acting β2-agonist therapy [budesonide/formoterol (BUD/FOR)] 400 µg/12 µg in patients with symptomatic COPD at risk of exacerbations. A subset participated for 52 weeks. Patient-reported assessments were: Evaluating Respiratory Symptoms in COPD™ (E-RS: COPD), St George’s Respiratory Questionnaire (SGRQ) for COPD, COPD Assessment Test (CAT), baseline and transitional dyspnea indices (TDI) and daily and global anchor questions for activity limitation. FF/UMEC/VI showed greater reductions from baseline in 4-weekly mean E-RS: COPD total and all subscale scores compared with BUD/FOR; differences were statistically significant (P < 0.05) at each time period. FF/UMEC/VI also demonstrated greater improvements from baseline at weeks 4 and 24 in SGRQ domain scores and TDI focal score compared with BUD/FOR. At weeks 4 and 24, improvements greater than the minimal clinically important difference from baseline were observed in CAT score with FF/UMEC/VI, but not BUD/FOR; differences were statistically significant (P ≤ 0.003). These findings demonstrate sustained daily symptom and HRQoL benefits of FF/UMEC/VI versus BUD/FOR. The inclusion of the CAT may provide data that are readily generalizable to everyday clinical practice. ClinicalTrials.gov number: NCT02345161. GSK." @default.
• W2783252549 created "2018-01-26" @default.
• W2783252549 creator A5007172600 @default.
• W2783252549 creator A5029172499 @default.
• W2783252549 creator A5034691201 @default.
• W2783252549 creator A5036734448 @default.
• W2783252549 creator A5049405030 @default.
• W2783252549 creator A5054097564 @default.
• W2783252549 creator A5073480128 @default.
• W2783252549 creator A5081388113 @default.
• W2783252549 date "2018-01-01" @default.
• W2783252549 modified "2023-10-04" @default.
• W2783252549 title "Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life" @default.
• W2783252549 cites W1930304162 @default.
• W2783252549 cites W1977849116 @default.
• W2783252549 cites W2009498514 @default.
• W2783252549 cites W2026656842 @default.
• W2783252549 cites W2027913623 @default.
• W2783252549 cites W2040229329 @default.
• W2783252549 cites W2086879933 @default.
• W2783252549 cites W2100182523 @default.
• W2783252549 cites W2104636056 @default.
• W2783252549 cites W2122716433 @default.
• W2783252549 cites W2123132046 @default.
• W2783252549 cites W2133284170 @default.
• W2783252549 cites W2142148686 @default.
• W2783252549 cites W2147004616 @default.
• W2783252549 cites W2157968241 @default.
• W2783252549 cites W2162689366 @default.
• W2783252549 cites W2164405525 @default.
• W2783252549 cites W2166780351 @default.
• W2783252549 cites W2167941825 @default.
• W2783252549 cites W2318749887 @default.
• W2783252549 cites W2508946237 @default.
• W2783252549 cites W2593670800 @default.
• W2783252549 cites W2604577460 @default.
• W2783252549 doi "https://doi.org/10.1007/s12325-017-0650-4" @default.
• W2783252549 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5778187" @default.
• W2783252549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29313286" @default.
• W2783252549 hasPublicationYear "2018" @default.
• W2783252549 type Work @default.
• W2783252549 sameAs 2783252549 @default.
• W2783252549 citedByCount "21" @default.
• W2783252549 countsByYear W27832525492018 @default.
• W2783252549 countsByYear W27832525492019 @default.
• W2783252549 countsByYear W27832525492020 @default.
• W2783252549 countsByYear W27832525492021 @default.
• W2783252549 countsByYear W27832525492022 @default.
• W2783252549 crossrefType "journal-article" @default.
• W2783252549 hasAuthorship W2783252549A5007172600 @default.
• W2783252549 hasAuthorship W2783252549A5029172499 @default.
• W2783252549 hasAuthorship W2783252549A5034691201 @default.
• W2783252549 hasAuthorship W2783252549A5036734448 @default.
• W2783252549 hasAuthorship W2783252549A5049405030 @default.
• W2783252549 hasAuthorship W2783252549A5054097564 @default.
• W2783252549 hasAuthorship W2783252549A5073480128 @default.
• W2783252549 hasAuthorship W2783252549A5081388113 @default.
• W2783252549 hasBestOaLocation W27832525491 @default.
• W2783252549 hasConcept C111278954 @default.
• W2783252549 hasConcept C126322002 @default.
• W2783252549 hasConcept C159110408 @default.
• W2783252549 hasConcept C168563851 @default.
• W2783252549 hasConcept C1862650 @default.
• W2783252549 hasConcept C203092338 @default.
• W2783252549 hasConcept C2776136866 @default.
• W2783252549 hasConcept C2776780178 @default.
• W2783252549 hasConcept C2776804153 @default.
• W2783252549 hasConcept C2777014857 @default.
• W2783252549 hasConcept C2779028295 @default.
• W2783252549 hasConcept C2779871671 @default.
• W2783252549 hasConcept C2779951463 @default.
• W2783252549 hasConcept C71924100 @default.
• W2783252549 hasConceptScore W2783252549C111278954 @default.
• W2783252549 hasConceptScore W2783252549C126322002 @default.
• W2783252549 hasConceptScore W2783252549C159110408 @default.
• W2783252549 hasConceptScore W2783252549C168563851 @default.
• W2783252549 hasConceptScore W2783252549C1862650 @default.
• W2783252549 hasConceptScore W2783252549C203092338 @default.
• W2783252549 hasConceptScore W2783252549C2776136866 @default.
• W2783252549 hasConceptScore W2783252549C2776780178 @default.
• W2783252549 hasConceptScore W2783252549C2776804153 @default.
• W2783252549 hasConceptScore W2783252549C2777014857 @default.
• W2783252549 hasConceptScore W2783252549C2779028295 @default.
• W2783252549 hasConceptScore W2783252549C2779871671 @default.
• W2783252549 hasConceptScore W2783252549C2779951463 @default.
• W2783252549 hasConceptScore W2783252549C71924100 @default.
• W2783252549 hasIssue "1" @default.
• W2783252549 hasLocation W27832525491 @default.
• W2783252549 hasLocation W27832525492 @default.
• W2783252549 hasLocation W27832525493 @default.
• W2783252549 hasLocation W27832525494 @default.
• W2783252549 hasLocation W27832525495 @default.
• W2783252549 hasOpenAccess W2783252549 @default.
• W2783252549 hasPrimaryLocation W27832525491 @default.
• W2783252549 hasRelatedWork W1986046118 @default.
• W2783252549 hasRelatedWork W2075905701 @default.
• W2783252549 hasRelatedWork W2165363684 @default.
• W2783252549 hasRelatedWork W2169621836 @default.

• next